Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Mid-range Performer
2796.8000 -107.90 (-3.71%)
NSE Mar 23, 2026 15:31 PM
Volume: 117.2K
 

logo
Ajanta Pharma Ltd.
01 Feb 2026
2796.80
-3.71%
ICICI Direct
Branded generics traction, US momentum key differentiators- Branded business growth in India was significantly above the trendline and without one-offs, driven by 16 new launches over the last 9-12 months and improved coverage. The US also maintained the growth tempo on account of 8 new launches over the last 9-12 months and market share gain in the existing products. US traction is contrary to the existing industry trend as the focus remains on specific launches. Africa branded continued to be driven by new launches. Asia branded on the other hand witnessed...
Promoters pledged 2.01% of shares in last quarter. Total pledge stands at 17.29% of promoter holdings
More from Ajanta Pharma Ltd.
Recommended